RCM
RA Capital Management Portfolio holdings
AUM
$5.94B
This Quarter Return
-8.53%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$3.75B
AUM Growth
+$3.75B
(-18%)
Cap. Flow
-$57.3M
Cap. Flow
% of AUM
-1.53%
Top 10 Holdings %
Top 10 Hldgs %
47.18%
Holding
110
New
14
Increased
9
Reduced
11
Closed
22
Top Buys
| 1 |
Veru
VERU
|
$89.3M |
| 2 |
PepGen
PEPG
|
$80.7M |
| 3 |
NSTG
NanoString Technologies, Inc.
NSTG
|
$45.5M |
| 4 |
Aclaris Therapeutics
ACRS
|
$36M |
| 5 |
Wave Life Sciences
WVE
|
$30.6M |
Top Sells
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$60.4M |
| 2 |
MacroGenics
MGNX
|
$53.8M |
| 3 |
Novavax
NVAX
|
$51M |
| 4 |
CNTA
Centessa Pharmaceuticals
CNTA
|
$32.1M |
| 5 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$29M |
Sector Composition
| 1 | Healthcare | 98.19% |
| 2 | Financials | 1.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Ascendis Pharma
ASND
$11.8B
| $704M | 18.76% | 7,567,900 | – | – |
|
2
Biogen
BIIB
$19.4B
| $148M | 3.95% | 727,024 | – | – |
|
3
Cytek Biosciences
CTKB
$527M
| $144M | 3.83% | 13,381,054 | – | – |
|
|
JBIO
4
Jade Biosciences, Inc. Common Stock
JBIO
$258M
| $129M | 3.44% | 8,263,982 | – | – |
|
5
Day One Biopharmaceuticals
DAWN
$769M
| $126M | 3.36% | 7,040,622 +980,532 | +16% | +$17.6M |
|
6
Travere Therapeutics
TVTX
$1.56B
| $119M | 3.18% | 4,922,941 | – | – |
|
7
Janux Therapeutics
JANX
$1.37B
| $106M | 2.82% | 8,670,644 | – | – |
|
8
Vaxcyte
PCVX
$4B
| $99.7M | 2.66% | 4,581,203 | – | – |
|
|
IMGN
9
DELISTED
Immunogen Inc
IMGN
| $97.8M | 2.61% | 21,741,458 | – | – |
|
10
Nkarta
NKTX
$151M
| $96.2M | 2.56% | 7,805,129 +2,200,000 | +39% | +$27.1M |
|
|
BLU
11
DELISTED
BELLUS Health Inc.
BLU
| $94.5M | 2.52% | 10,230,274 | – | – |
|
12
iTeos Therapeutics
ITOS
| $91M | 2.43% | 4,417,259 | – | – |
|
|
13
Veru
VERU
$47.6M
| $89.3M | 2.38% | +7,900,000 | New | +$89.3M |
|
|
DICE
14
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $80.8M | 2.16% | 5,208,911 | – | – |
|
|
15
PepGen
PEPG
$38M
| $80.8M | 2.15% | +8,131,952 | New | +$80.7M |
|
|
FMTX
16
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $62.1M | 1.66% | 9,011,651 | – | – |
|
|
17
Aclaris Therapeutics
ACRS
$209M
| $61.4M | 1.64% | 4,398,453 +2,580,645 | +142% | +$36M |
|
|
PNT
18
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $61.3M | 1.63% | 9,003,018 | – | – |
|
19
Celldex Therapeutics
CLDX
$1.47B
| $55.9M | 1.49% | 2,075,000 | – | – |
|
|
20
Wave Life Sciences
WVE
$1.53B
| $55.9M | 1.49% | 17,202,009 +9,426,802 | +121% | +$30.6M |
|
21
Vor Biopharma
VOR
$250M
| $55.3M | 1.47% | 11,120,973 | – | – |
|
|
KNTE
22
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $53.8M | 1.43% | 4,264,144 | – | – |
|
23
Tyra Biosciences
TYRA
$675M
| $51.7M | 1.38% | 7,236,454 | – | – |
|
24
GH Research
GHRS
$837M
| $48.9M | 1.3% | 4,898,373 +71,043 | +1% | +$709K |
|
25
Geron
GERN
$893M
| $46.7M | 1.25% | 30,126,299 | – | – |
|